安非他明
甲基苯丙胺
心情
认知
MDMA公司
药品
心理学
精神科
抗抑郁药
医学
神经科学
焦虑
多巴胺
出处
期刊:International Review of Neurobiology
日期:2015-01-01
卷期号:: 9-25
被引量:68
标识
DOI:10.1016/bs.irn.2015.02.001
摘要
Amphetamine was discovered as a drug in the late 1920s, and its pharmacological effects on attention and cognition, emotions, and appetite were explored thoroughly in the 1930s and 1940s. By the late 1940s, it had achieved medical and market success as an antidepressant and was quickly gaining such success as a diet medication. In contrast, both careful testing and extensive military experience had left the impression that the drugs' benefits for attention and cognition were more subjective than real and that any objective benefits were explained mainly by the drug's mood-elevating effects. Because of its unpatentable status, methamphetamine had been introduced for all the same uses by drug firms competing with the holder of the amphetamine patent. The drugs were being widely used nonmedically and their abuse potential was becoming recognized by medicine, eventually leading to their strict control internationally around 1970.
科研通智能强力驱动
Strongly Powered by AbleSci AI